SCHEMBL22952966

SCHEMBL22952966

CC(C)(CO)C1Cc2c(ccc(O)c2O)C(CN)O1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 19/20 0.79
KDM4E B2RXH2 2/20 0.55
TP53 P04637 2/20 0.55
CYP3A4 P08684 2/20 0.55
CYP2D6 P10635 2/20 0.55
MAPT P10636 2/20 0.55
CYP2C19 P33261 2/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2C9 P11712 1/20 0.55
HSD17B10 Q99714 1/20 0.55
MEN1 O00255 1/20 0.53
NPC1 O15118 1/20 0.53
ALDH1A1 P00352 1/20 0.53
DRD2 P14416 1/20 0.53
HPGD P15428 1/20 0.53
NFKB1 P19838 1/20 0.53
MAPK1 P28482 1/20 0.53
THPO P40225 1/20 0.53
MTOR P42345 1/20 0.53
RAB9A P51151 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7439885 0.88 DRD1 (1.00) DRD1KDM4ETP53CYP3A4CYP2D6
SCHEMBL7445752 0.88 DRD1 (1.00) DRD1KDM4ETP53CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL7320564 0.87 DRD1 (0.97) DRD1KDM4ETP53CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL9670199 0.87 DRD1 (0.97) DRD1KDM4ETP53CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL8829240 0.87 DRD1 (0.97) DRD1KDM4ETP53CYP3A4CYP2D6
SCHEMBL7447531 0.78 DRD1 (0.74) DRD1KDM4ETP53CYP3A4CYP2D6
SCHEMBL7440749 0.78 DRD1 (0.74) DRD1KDM4ETP53CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL7442166 0.77 DRD1 (0.72) DRD1KDM4ETP53CYP3A4CYP2D6
SCHEMBL9038200 0.77 DRD1 (0.77) DRD1KDM4ETP53CYP3A4CYP2D6
SCHEMBL10379926 0.77 DRD1 (0.77) DRD1KDM4ETP53CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021021922-A1 COMPOUNDS AND METHODS FOR TREATING FIBROTIC PATHOLOGIES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2021-02-04 WO disclosed